Income Statement OneMedNet Corporation NYSE

Stocks

ONMD

US68270C1036

Business Support Services

Market Closed - NYSE 16:00:00 2026-09-18 EDT			5-day change	1st Jan Change
0.7000 ^USD	+14.57%		-8.33%	-90.98%

08-31	OneMedNet Corporation Delivers Full-Fidelity Clinical Real-World Data To AI-Driven Drug Development Company	CI
08-14	OneMedNet Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

c9e974a009f93497ffae84241058.m1ouWrxGZQr3UoQRdwx6A6GOpCJgqzGjqcZiLOSIq94.6xh8adYuIHukE-BfOEI0TffU7hQZ5XWW8YAWda_j8Y_9Ph8j7isca8dm9w

Published financial data: ONEMEDNET CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	1.09M	1.15M	1.02M	643K	1.36M
Total Revenues	1.09M	1.15M	1.02M	643K	1.36M
Cost of Goods Sold, Total	1.21M	1.51M	1.15M	924K	1.86M
Gross Profit	-113K	-361K	-128K	-281K	-503K
Selling General & Admin Expenses, Total	1.95M	4.8M	6.61M	7.86M	7.65M
R&D Expenses	643K	953K	1.63M	1.47M	1.52M
Other Operating Expenses, Total	2.6M	5.76M	8.25M	9.32M	9.16M
Operating Income	-2.71M	-6.12M	-8.37M	-9.6M	-9.67M
Interest Expense, Total	-195K	-403K	-749K	-147K	-67K
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-195K	-403K	-749K	-147K	-67K
Other Non Operating Income (Expenses)	-34.9K	-46.82K	-3.58M	-375K	1.41M
EBT, Excl. Unusual Items	-2.94M	-6.57M	-12.7M	-10.13M	-8.33M
Asset Writedown	-	-	-10.5M	-	-
Other Unusual Items	-	-	-	-	5.53M
EBT, Incl. Unusual Items	-2.94M	-6.57M	-23.21M	-10.13M	-2.8M
Income Tax Expense	-	-	-	2K	1K
Earnings From Continuing Operations	-2.94M	-6.57M	-23.21M	-10.13M	-2.8M
Net Income to Company	-2.94M	-6.57M	-23.21M	-10.13M	-2.8M
Net Income - (IS)	-2.94M	-6.57M	-23.21M	-10.13M	-2.8M
Net Income to Common Incl Extra Items	-2.94M	-6.57M	-23.21M	-10.13M	-2.8M
Net Income to Common Excl. Extra Items	-2.94M	-6.57M	-23.21M	-10.13M	-2.8M
Per Share Items
Net EPS - Basic	-0.2	-1.44	-0.98	-0.36	-0.06
Basic EPS - Continuing Operations	-0.2	-1.44	-0.98	-0.36	-0.06
Basic Weighted Average Shares Outstanding	14.96M	4.56M	23.57M	28.08M	44.55M
Net EPS - Diluted	-0.2	-1.44	-0.98	-0.36	-0.06
Diluted EPS - Continuing Operations	-0.2	-1.44	-0.98	-0.36	-0.06
Diluted Weighted Average Shares Outstanding	14.96M	4.56M	23.57M	28.08M	44.55M
Normalized Basic EPS	-0.12	-0.9	-0.34	-0.23	-0.12
Normalized Diluted EPS	-0.12	-0.9	-0.34	-0.23	-0.12
Supplemental Items
EBITDA	-2.7M	-6.09M	-8.35M	-9.55M	-9.6M
EBITA	-2.71M	-6.12M	-8.37M	-9.6M	-9.67M
EBIT	-2.71M	-6.12M	-8.37M	-9.6M	-9.67M
Total Revenues (As Reported)	-	-	-	643K	1.36M
Effective Tax Rate - (Ratio)	-	-	-	-0.02	-0.04
Normalized Net Income	-1.84M	-4.1M	-7.94M	-6.33M	-5.2M
Supplemental Operating Expense Items
Selling and Marketing Expenses	605K	958K	1.11M	830K	1.27M
General and Administrative Expenses	1.2M	3.45M	5.27M	7.03M	6.38M
Research And Development Expense From Footnotes	643K	953K	1.63M	1.47M	1.52M
Stock-Based Comp., COGS (Total)	-	-	-	-	55K
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	115K
Stock-Based Comp., S&M Exp. (Total)	-	-	-	-	75K
Stock-Based Comp., G&A Exp. (Total)	-	1.59M	-	-	1.79M
Stock-Based Comp., Other (Total)	97.87K	7.71K	-	14.68M	-
Total Stock-Based Compensation	97.87K	1.6M	-	14.68M	2.03M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	699K	271K	47.01K	172K	585K
Total Cash And Short Term Investments	699K	271K	47.01K	172K	585K
Accounts Receivable, Total	91.74K	18.98K	152K	213K	495K
Other Receivables	-	900K	-	-	-
Total Receivables	91.74K	919K	152K	213K	495K
Prepaid Expenses	42.23K	101K	166K	385K	509K
Other Current Assets, Total	-	-	-	2.85M	506K
Total Current Assets	833K	1.29M	364K	3.62M	2.1M
Gross Property Plant And Equipment	207K	263K	282K	324K	338K
Accumulated Depreciation	-157K	-180K	-183K	-216K	-282K
Net Property Plant And Equipment	49.77K	83.1K	98.87K	108K	56K
Total Assets	883K	1.37M	463K	3.73M	2.15M
Liabilities
Accounts Payable, Total	759K	1.13M	4.18M	6.37M	-
Accrued Expenses, Total	-	-	113K	-	3.5M
Short-term Borrowings	-	-	4.59M	8.76M	754K
Current Portion of Long-Term Debt	3.35M	8.49M	44.67K	-	-
Current Income Taxes Payable	-	-	120K	-	-
Unearned Revenue Current, Total	642K	184K	254K	561K	389K
Other Current Liabilities	-	-	3.52M	3.53M	186K
Total Current Liabilities	4.75M	9.81M	12.83M	19.23M	4.82M
Long-Term Debt	1.55M	1.54M	465K	-	220K
Other Non Current Liabilities	288K	691K	24.58K	449K	71K
Total Liabilities	6.59M	12.04M	13.32M	19.68M	5.12M
Preferred Stock Convertible	705	705	-	-	-
Total Preferred Equity	705	705	-	-	-
Common Stock, Total	434	455	2.36K	2K	2K
Additional Paid In Capital	19.61M	21.21M	42.22M	86.15M	102M
Retained Earnings	-25.31M	-31.88M	-55.08M	-102M	-104M
Treasury Stock	-	-	-	-529K	-529K
Total Common Equity	-5.7M	-10.67M	-12.86M	-15.95M	-2.96M
Total Equity	-5.7M	-10.67M	-12.86M	-15.95M	-2.96M
Total Liabilities And Equity	883K	1.37M	463K	3.73M	2.15M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	14.96M	7.57M	23.85M	30.76M	52.2M
ECS Total Common Shares Outstanding	14.96M	7.57M	23.57M	27.99M	51.98M
Book Value / Share	-0.38	-1.41	-0.55	-0.57	-0.06
Tangible Book Value	-5.7M	-10.67M	-12.86M	-15.95M	-2.96M
Tangible Book Value Per Share	-0.38	-1.41	-0.55	-0.57	-0.06
Total Debt	4.9M	10.03M	5.1M	8.76M	974K
Net Debt	4.2M	9.76M	5.05M	8.59M	389K
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	207K	263K	282K	324K	338K
Full Time Employees	12	12	20	21	22
Part Time Employees	-	-	-	1	1
Accumulated Allowance for Doubtful Accounts (Supple)	22.53K	103K	-	-	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-2.94M	-6.57M	-23.21M	-10.13M	-2.8M
Depreciation & Amortization - CF	14.47K	24.81K	27.98K	57K	65K
Depreciation & Amortization, Total	14.47K	24.81K	27.98K	57K	65K
Asset Writedown & Restructuring Costs	-	-	-	-	-5.57M
Stock-Based Compensation (CF)	97.87K	1.6M	-	628K	2.03M
Other Operating Activities, Total	-	-	900K	956K	-1.34M
Change In Accounts Receivable	81.09K	-52.47K	-133K	-61K	-282K
Change In Accounts Payable	368K	376K	1.37M	1.49M	366K
Change in Unearned Revenues	536K	-459K	70.31K	307K	-172K
Change In Income Taxes	-	-	-94.83K	-	-
Change in Other Net Operating Assets	-631	-834K	29.29M	-234K	194K
Cash from Operations	-1.84M	-5.91M	8.22M	-6.98M	-7.5M
Capital Expenditure	-29.94K	-58.14K	-43.76K	-51K	-13K
Other Investing Activities, Total	-	-	-	-1.93M	2.32M
Cash from Investing	-29.94K	-58.14K	-43.76K	-1.98M	2.31M
Short Term Debt Issued, Total	-	-	1.55M	3.85M	-
Long-Term Debt Issued, Total	2.49M	5.54M	466K	-	-
Total Debt Issued	2.49M	5.54M	2.02M	3.85M	-
Short Term Debt Repaid, Total	-	-	-	-700K	-262K
Long-Term Debt Repaid, Total	-	-2.75K	-10.68M	-30K	-401K
Total Debt Repaid	-	-2.75K	-10.68M	-730K	-663K
Issuance of Common Stock	-	-	18.19M	6.27M	4.25M
Repurchase of Common Stock	-	-	-28.75M	-200K	-
Other Financing Activities, Total	-	-	10.79M	-100K	2.02M
Cash from Financing	2.49M	5.54M	-8.43M	9.09M	5.61M
Miscellaneous Cash Flow Adjustments	-	-1	-	-	-
Net Change in Cash	620K	-428K	-255K	125K	413K
Supplemental Items
Cash Interest Paid	-	-	-	26K	23K
Cash Income Tax Paid (Refund)	-	-	-	18K	1K
Levered Free Cash Flow	-750K	-3.48M	28.93M	7.18M	-7.84M
Unlevered Free Cash Flow	-628K	-3.23M	29.4M	7.27M	-7.8M
Change In Net Working Capital	-984K	969K	-34.65M	1.41M	3.84M
Net Debt Issued / Repaid	2.49M	5.54M	-8.67M	3.12M	-663K

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-279.79	-338.72	-33.88	-286.48	-205.58
Return on Total Capital	317.11	530.59	-73.13	77.29	141.13
Return On Equity %	68.69	80.21	1.29K	68.92	29.62
Return on Common Equity	68.68	80.21	1.29K	68.92	29.62
Margin Analysis
Gross Profit Margin %	-10.39	-31.29	-12.52	-43.7	-37.01
SG&A Margin	179.01	416.64	647.46	1.22K	562.84
EBITDA Margin %	-246.95	-528.43	-816.94	-1.48K	-706.55
EBITA Margin %	-248.27	-530.58	-819.68	-1.49K	-711.33
EBIT Margin %	-248.27	-530.58	-819.68	-1.49K	-711.33
Income From Continuing Operations Margin %	-269.36	-569.63	-2.27K	-1.58K	-206.11
Net Income Margin %	-269.36	-569.63	-2.27K	-1.58K	-206.11
Net Avail. For Common Margin %	-269.36	-569.63	-2.27K	-1.58K	-206.11
Normalized Net Income Margin	-168.35	-356.02	-777	-984.35	-383
Levered Free Cash Flow Margin	-68.67	-301.65	2.83K	1.12K	-576.95
Unlevered Free Cash Flow Margin	-57.48	-279.78	2.88K	1.13K	-573.87
Asset Turnover
Asset Turnover	1.8	1.02	0.07	0.31	0.46
Fixed Assets Turnover	25.97	17.35	11.23	6.21	16.57
Receivables Turnover (Average Receivables)	7.61	20.82	11.98	3.52	3.84
Short Term Liquidity
Current Ratio	0.18	0.13	0.03	0.19	0.43
Quick Ratio	0.17	0.12	0.02	0.02	0.22
Operating Cash Flow to Current Liabilities	-0.39	-0.6	0.64	-0.36	-1.56
Days Sales Outstanding (Average Receivables)	47.99	17.53	30.48	103.88	95.08
Average Days Payable Outstanding	174.13	228.34	1.11K	2.19K	-
Long Term Solvency
Total Debt/Equity	-85.87	-94.05	-39.67	-54.94	-32.85
Total Debt / Total Capital	-607.77	-1.58K	-65.75	-121.93	-48.92
LT Debt/Equity	-27.13	-14.47	-3.62	-	-7.42
Long-Term Debt / Total Capital	-191.99	-243.1	-5.99	-	-11.05
Total Liabilities / Total Assets	745.78	876.5	2.88K	527.96	237.84
EBIT / Interest Expense	-13.87	-15.17	-11.18	-65.34	-144.28
EBITDA / Interest Expense	-13.8	-15.1	-11.14	-64.95	-143.31
(EBITDA - Capex) / Interest Expense	-13.95	-15.25	-11.2	-65.3	-143.51
Total Debt / EBITDA	-1.82	-1.65	-0.61	-0.92	-0.1
Net Debt / EBITDA	-1.56	-1.6	-0.61	-0.9	-0.04
Total Debt / (EBITDA - Capex)	-1.8	-1.63	-0.61	-0.91	-0.1
Net Debt / (EBITDA - Capex)	-1.54	-1.59	-0.6	-0.89	-0.04
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	32.49	5.58	-11.37	-37.02	111.35
Gross Profit, 1 Yr. Growth %	-153.4	218.05	-64.54	117.83	79
EBITDA, 1 Yr. Growth %	-7.61	125.93	-26.79	39.9	0.57
EBITA, 1 Yr. Growth %	-7.56	125.64	-26.71	40.16	0.65
EBIT, 1 Yr. Growth %	-7.56	125.64	-26.71	40.16	0.65
Earnings From Cont. Operations, 1 Yr. Growth %	4.23	123.28	272.5	-70.01	-72.35
Net Income, 1 Yr. Growth %	4.23	123.28	272.5	-70.01	-72.35
Normalized Net Income, 1 Yr. Growth %	-3.77	123.28	71.95	-70	-17.76
Diluted EPS Before Extra, 1 Yr. Growth %	-	111.76	-27.94	-92.23	-82.57
Accounts Receivable, 1 Yr. Growth %	-53.04	-79.32	699.16	40.13	132.39
Net Property, Plant and Equip., 1 Yr. Growth %	45.11	66.97	18.98	9.09	-48.15
Total Assets, 1 Yr. Growth %	169.3	55.6	-98.48	703.23	-42.29
Tangible Book Value, 1 Yr. Growth %	99.39	87.08	-238.67	18.66	-81.41
Common Equity, 1 Yr. Growth %	99.39	87.08	-238.67	18.66	-81.41
Cash From Operations, 1 Yr. Growth %	-13.21	220.47	-90.58	45.75	7.93
Capital Expenditures, 1 Yr. Growth %	-	94.2	-24.73	15.91	-74.51
Levered Free Cash Flow, 1 Yr. Growth %	-	363.82	-185.43	-77.22	4.75
Unlevered Free Cash Flow, 1 Yr. Growth %	-	413.91	-187.47	-76.94	5.49
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	18.27	-3.26	-25.31	15.37
Gross Profit, 2 Yr. CAGR %	-	30.32	6.2	-11.74	97.46
EBITDA, 2 Yr. CAGR %	-	44.48	75.94	-8.49	18.61
EBITA, 2 Yr. CAGR %	-	44.43	75.77	-8.31	18.77
EBIT, 2 Yr. CAGR %	-	44.43	75.77	-8.31	18.77
Earnings From Cont. Operations, 2 Yr. CAGR %	-	52.55	180.9	27.51	-71.2
Net Income, 2 Yr. CAGR %	-	52.55	180.9	27.51	-71.2
Normalized Net Income, 2 Yr. CAGR %	-	46.58	107.82	17.09	-50.33
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	20.32	-48.61	-88.37
Accounts Receivable, 2 Yr. CAGR %	-	-68.84	28.56	235.04	80.46
Net Property, Plant and Equip., 2 Yr. CAGR %	-	55.66	40.95	14	-24.79
Total Assets, 2 Yr. CAGR %	-	104.7	-27.59	-65.01	115.31
Tangible Book Value, 2 Yr. CAGR %	-	93.14	50.16	31.15	-53.03
Common Equity, 2 Yr. CAGR %	-	93.14	50.16	31.15	-53.03
Cash From Operations, 2 Yr. CAGR %	-	66.78	111.12	-71.71	25.14
Capital Expenditures, 2 Yr. CAGR %	-	-	20.9	-6.34	-45.64
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	521.18	-53.96	-50.12
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	584.4	-53.49	-50.26
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	7.43	-16.18	5.64
Gross Profit, 3 Yr. CAGR %	-	-	-15.55	35.32	11.72
EBITDA, 3 Yr. CAGR %	-	-	41.95	52.43	-5.56
EBITA, 3 Yr. CAGR %	-	-	41.88	52.46	-5.42
EBIT, 3 Yr. CAGR %	-	-	41.88	52.46	-5.42
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	101.85	51.02	-23.39
Net Income, 3 Yr. CAGR %	-	-	101.85	51.02	-23.39
Normalized Net Income, 3 Yr. CAGR %	-	-	60.78	51.01	4.08
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-19.05	-64.16
Accounts Receivable, 3 Yr. CAGR %	-	-	-8.1	32.42	196.58
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	42.32	29.47	-12.33
Total Assets, 3 Yr. CAGR %	-	-	12.19	61.61	-58.65
Tangible Book Value, 3 Yr. CAGR %	-	-	65.05	40.89	-31.62
Common Equity, 3 Yr. CAGR %	-	-	65.05	40.89	-31.62
Cash From Operations, 3 Yr. CAGR %	-	-	56.98	55.86	-55.86
Capital Expenditures, 3 Yr. CAGR %	-	-	-	19.43	-39.3
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	112.34	-38.59
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	126.27	-38.55
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	10.52
Gross Profit, 5 Yr. CAGR %	-	-	-	-	18.82
EBITDA, 5 Yr. CAGR %	-	-	-	-	26.9
EBITA, 5 Yr. CAGR %	-	-	-	-	26.95
EBIT, 5 Yr. CAGR %	-	-	-	-	26.95
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	-0.15
Net Income, 5 Yr. CAGR %	-	-	-	-	-0.15
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	22.2
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	20.43
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	10.3
Total Assets, 5 Yr. CAGR %	-	-	-	-	45.67
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	0.72
Common Equity, 5 Yr. CAGR %	-	-	-	-	0.72
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	28.7